Clinical Trial Update: Safety and Immune Response Assessment Study of Killed-whole HIV-1 Vaccine (SAV001-H) in Chronic HIV-1 Infected Patients [Phase 1]

View source ↗

Summary

Phase 1 trial update reporting safety and immune response data for the killed-whole HIV-1 vaccine SAV001-H in adults with chronic HIV infection. The study statu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• SAV001-H (Killed-whole HIV-1 vaccine)

Snippet

Sponsor: Sumagen | Conditions: HIV Infections | Phase 1 | Status: COMPLETED